Kranzler HR - Search Results

1

Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol.

Blomqvist O, Hernandez-Avila CA, Van Kirk J, Rose JE, Kranzler HR. Blomqvist O, et al. Among authors: kranzler hr. Alcohol Clin Exp Res. 2002 Mar;26(3):326-31. Alcohol Clin Exp Res. 2002. PMID: 11923584

2

Problems associated with average alcohol consumption and frequency of intoxication in a medical population.

Kranzler HR, Babor TF, Lauerman RJ. Kranzler HR, et al. Alcohol Clin Exp Res. 1990 Feb;14(1):119-26. doi: 10.1111/j.1530-0277.1990.tb00457.x. Alcohol Clin Exp Res. 1990. PMID: 2178464

3

Elevated rates of early discontinuation from pharmacotherapy trials in alcoholics and drug abusers.

Kranzler HR, Escobar R, Lee DK, Meza E. Kranzler HR, et al. Alcohol Clin Exp Res. 1996 Feb;20(1):16-20. doi: 10.1111/j.1530-0277.1996.tb01036.x. Alcohol Clin Exp Res. 1996. PMID: 8651447 Review.

4

Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer.

Del Boca FK, Kranzler HR, Brown J, Korner PF. Del Boca FK, et al. Among authors: kranzler hr. Alcohol Clin Exp Res. 1996 Nov;20(8):1412-7. doi: 10.1111/j.1530-0277.1996.tb01142.x. Alcohol Clin Exp Res. 1996. PMID: 8947318 Clinical Trial.

5

No association of PROP taster status and paternal history of alcohol dependence.

Kranzler HR, Moore PJ, Hesselbrock VM. Kranzler HR, et al. Alcohol Clin Exp Res. 1996 Nov;20(8):1496-500. doi: 10.1111/j.1530-0277.1996.tb01154.x. Alcohol Clin Exp Res. 1996. PMID: 8947330

6

Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics.

Kranzler HR, Burleson JA, Brown J, Babor TF. Kranzler HR, et al. Alcohol Clin Exp Res. 1996 Dec;20(9):1534-41. doi: 10.1111/j.1530-0277.1996.tb01696.x. Alcohol Clin Exp Res. 1996. PMID: 8986200 Clinical Trial.

7

Treatment of inhalant-induced psychotic disorder with carbamazepine versus haloperidol.

Hernandez-Avila CA, Ortega-Soto HA, Jasso A, Hasfura-Buenaga CA, Kranzler HR. Hernandez-Avila CA, et al. Among authors: kranzler hr. Psychiatr Serv. 1998 Jun;49(6):812-5. doi: 10.1176/ps.49.6.812. Psychiatr Serv. 1998. PMID: 9634163 Clinical Trial.

8

Sustained-release naltrexone for alcoholism treatment: a preliminary study.

Kranzler HR, Modesto-Lowe V, Nuwayser ES. Kranzler HR, et al. Alcohol Clin Exp Res. 1998 Aug;22(5):1074-9. Alcohol Clin Exp Res. 1998. PMID: 9726277 Clinical Trial.

9

Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1).

Kranzler HR, Gelernter J, O'Malley S, Hernandez-Avila CA, Kaufman D. Kranzler HR, et al. Alcohol Clin Exp Res. 1998 Sep;22(6):1359-62. Alcohol Clin Exp Res. 1998. PMID: 9756053

10

Naltrexone treatment of comorbid alcohol and cocaine use disorders.

Hersh D, Van Kirk JR, Kranzler HR. Hersh D, et al. Among authors: kranzler hr. Psychopharmacology (Berl). 1998 Sep;139(1-2):44-52. doi: 10.1007/s002130050688. Psychopharmacology (Berl). 1998. PMID: 9768541 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

654 results

Search Page

Filters